enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in enVVeno Medical Corp as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- 0 vs. Q1 2022
- Shares held
- 2.15M
- +107.4K (+5.3%) vs. Q1 2022
- Total value
- $8.11M
- −$4.87M (−37.5%) vs. Q1 2022
- New holders
- 3
- 6 more added
- Sold out
- 3
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 781,615 | $2.95M | 0.09% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 401,200 | $1.52M | 2.12% | 00.0% | Unchanged |
| Vanguard Group Inc | 335,631 | $1.27M | 0.00% | +56,844+20.4% | Added |
| Kingdon Capital Management, L.L.C. | 219,180 | $829.0K | 0.22% | 00.0% | Unchanged |
| UBS Oconnor LLC | 118,113 | $446.0K | 0.00% | +118,113 | New |
| Geode Capital Management, LLC | 81,723 | $308.0K | 0.00% | +1,678+2.1% | Added |
| Two Sigma Advisers, LP | 37,000 | $140.0K | 0.00% | −12,600−25.4% | Reduced |
| BlackRock Inc. | 33,410 | $127.0K | 0.00% | −5,031−13.1% | Reduced |
| Morgan Stanley | 28,280 | $107.0K | 0.00% | −7,674−21.3% | Reduced |
| Arthur M. Cohen & Associates, LLC | 24,000 | $91.0K | 0.02% | +9,000+60.0% | Added |
| State Street Corp | 21,500 | $81.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,906 | $53.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 11,595 | $44.0K | 0.00% | +10,800+1,358.5% | Added |
| Susquehanna International Group, LLP | 11,169 | $42.0K | 0.00% | +11,169 | New |
| Sepio Capital, LP | 10,800 | $41.0K | 0.00% | +10,800 | New |
| Millennium Management LLC | 10,651 | $40.0K | 0.00% | −413−3.7% | Reduced |
| Financial Perspectives, Inc | 3,278 | $12.4K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 2,049 | $8.00K | 0.00% | +4+0.2% | Added |
| Tower Research Capital LLC (TRC) | 541 | $2.00K | 0.00% | +236+77.4% | Added |
| UBS Group AG | 264 | $1.00K | 0.00% | −297−52.9% | Reduced |
| Newbridge Financial Services Group, Inc. | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Kepos Capital LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −33,372−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −1,861−100.0% | Sold out |